MAGDALA PAUL: Open Payments
NPI 1992103469 · MARGATE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 45 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $705 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $108 |
| PFIZER INC. | 5 | $103 |
| Novo Nordisk Inc | 4 | $91 |
| Insmed, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Exact Sciences Corporation | 3 | $72 |
| Abbott Laboratories | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $37 |
| Amgen Inc. | 2 | $31 |
Products named: MOUNJARO, Arikayce, AIRSUPRA, The Cologuard Plus Collection Kit, ELIQUIS, FREESTYLE LIBRE, GEMTESA, Ozempic.
Industry payments across FL — which companies pay providers there.
